Key Record Dates
| ClinicalTrials.gov Identifier: | NCT01430390 |
|---|---|
| Brief Title: | In Vitro Expanded Allogeneic Epstein-Barr Virus Specific Cytotoxic T-Lymphocytes (EBV-CTLs) Genetically Targeted to the CD19 Antigen in B-cell Malignancies |
| First Submitted : | September 6, 2011 |
| First Submitted that Met QC Criteria : | September 7, 2011 |
| First Posted : | September 8, 2011 (Estimate) |
| Last Update Submitted that Met QC Criteria : | February 10, 2021 |
| Last Update Posted : | February 11, 2021 |